OUR PURPOSE PIONEERING SCIENCE PATIENTS OUR PEOPLE ENVIRONMENT COMMUNITY REPORTING 57 WORKING AT THE INTERSECTION OF TECHNOLOGY AND WELL-BEING BIOGEN 2021 YEAR IN REVIEW 2021 DE&I Clinical Research Goals and Areas of Focus GOALS 2021 HIGHLIGHTS Build trust and relationships in UP communities through trusted partners and sustained commitments with local and national leaders • Advised on UP engagement and educational assets, Biogen Trial Link, Alzheimer’s disease program and study designs for BIIB080 and ADUHELM, and lupus community outreach event topics, as Community Advisory Board (CAB). • Expanded CAB to include representation from Asian American, Pacific Islander and Native American communities. • Received Reuters Global Pharma Patient Champion Award for CAB. • Built sustained community outreach and education programs including CISCRP AWARE, Proximity Health Solutions, HEAL Collaborative and Bright Focus Foundation Virtual Community Outreach Series. Demonstrate an increase in the diversity and representation of our clinical participants that reflects the epidemiology of the disease • Initiated UP strategy and set recruitment targets for 14 studies (100% completed). • Launched internal participant demographic distribution dashboard. • Introduced bespoke strategy for ongoing acute stroke study. Meet patients where they are: Bring clinical trials to UP communities • Launched NMQF Clinical Trial Index and Clinical Trial Learning Community. • Selected Boston Medical Center for TOPAZ study and community events. • Launched suite of DE&I in clinical trials educational assets. • Launched DE&I training for clinical trial sites. • Initiated global efforts to research and identify UP needs and areas of focus at country level. • Supported market research in lupus and Alzheimer’s disease. Champion internal and external change to drive DE&I in clinical trials • Supported and led various DE&I initiatives and projects as UP champions. • Participated in R&D Process Owner Network DE&I conference. • Launched study management team UP goal setting and baseline guidance. • Presented to U.K.’s DE&I Committee for awareness raising. • Participated in Health Equity Ideas Café three-part series. • Represented DE&I efforts on various conference panels and summits • Presented on diversity in clinical trials for the U.K. NIHR and Dementia Industry Group Webinar Series. • Submitted ACTRIMS abstract for MS Demographic Distribution of Biogen’s clinical trials. Strengthen existing and form new partnerships with trusted local and national leaders driving DE&I in clinical trials • Benchmarked diversity and disparities among clinical trials as members of Investigative Site Diversity Initiative for Tufts Center for the Study of Drug Development sites. • Participated as research group members in CISCRP Perceptions and Insights Study. • Supplemented sponsorships for CISCRP Diversity Campaign and Clinical Trial Awareness. • Participated in CISCRP Diversity in Clinical Trials Working Group • Initiated CVS Health partnership to build UP community outreach, data utilization, study specific recruitment efforts, study sites and decentralized models. • Joined Association of Clinical Research Professionals.